Tissue Matrix News Today

AIGH Capital Management LLC increased its stake in shares of TELA Bio, Inc. (NASDAQ:TELA – Free Report) by 10.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,377,945 shares of the company’s stock after buying an additional 125,000 shares during the […]

JMP Securities reissued their market outperform rating on shares of TELA Bio (NASDAQ:TELA – Free Report) in a report issued on Friday, Benzinga reports. JMP Securities currently has a $15.00 price target on the stock. Several other research firms also recently commented on TELA. Piper Sandler decreased their price objective on TELA Bio from $15.00 […]

TELA Bio (NASDAQ:TELA – Free Report) had its price target reduced by Piper Sandler from $15.00 to $12.00 in a research report report published on Friday morning, Benzinga reports. They currently have an overweight rating on the stock. Separately, Lake Street Capital reiterated a buy rating and set a $14.00 price target on shares of […]

TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) insider Gregory A. Firestone bought 2,600 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was bought at an average price of $5.65 per share, with a total value of $14,690.00. Following the purchase, the insider now owns 35,511 shares in the […]

Stonepine Capital Management LLC purchased a new stake in shares of TELA Bio, Inc. (NASDAQ:TELA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 482,619 shares of the company’s stock, valued at approximately $4,889,000. TELA Bio accounts for […]

TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CEO Antony Koblish acquired 11,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were purchased at an average cost of $4.54 per share, with a total value of $49,940.00. Following the completion of the acquisition, the chief executive officer […]

TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CFO Roberto Cuca purchased 10,000 shares of TELA Bio stock in a transaction that occurred on Tuesday, November 14th. The stock was acquired at an average cost of $4.49 per share, with a total value of $44,900.00. Following the acquisition, the chief financial officer now directly owns […]

New addition expands reconstruction options for surgeons and patientsMALVERN, Pa., Aug. 16, 2023 -- TELA Bio, Inc. , a commercial-stage medical technology company focused on providing innovative... -Today at 07:02 am- MarketScreener

GlucoTrack (NASDAQ:GCTK – Get Rating) and TELA Bio (NASDAQ:TELA – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Risk & Volatility GlucoTrack has a beta of -1.13, indicating […]

Sanders Morris Harris LLC cut its holdings in TELA Bio, Inc. (NASDAQ:TELA – Get Rating) by 17.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 69,168 shares of the company’s stock after selling 14,200 shares during the quarter. Sanders Morris Harris LLC owned […]